More than a third of the German population would not inject themselves with a new type of coronavirus (SARS-CoV-2) vaccine developed in collaboration with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca, a survey found.
According to the polling company Civey, which conducts online surveys, the German population 34.8 percent would definitely miss the AstraZeneca vaccine, and would rather wait for the possibility of obtaining a different type of vaccine despite the epidemic.
In Germany, the vaccine has been introduced with an age restriction, only those between the ages of 18 and 64 can receive it. Although both the government and the so-called Standing Vaccination Commission (STIKO), a government advisory body of independent experts, emphasize that this is simply because there are not enough data for unrestricted use and the vaccine is effective and safe, yet, public distrust developed, as indicated by the Civey survey.
Abstinence from the three vaccines that can be used against SARS-CoV-2 is specific to AstraZeneca. This is shown by while shipments of BioNTech / Pfizer and Moderna vaccine are running out according to the vaccination plan, AstraZeneca’s vaccine is reported in around 650,000 doses in warehouses nationwide, mainly because many people do not go to get the vaccine when they find out they are getting it from the least popular vaccine.
According to a widespread description in the German press, an “image problem” emerged. This, in addition to the age restriction reservations, can be attributed to the fact that Compared to BioNTech / Pfizer and Moderna, the effectiveness of AstraZeneca vaccination is low and it is doubtful how well it protects against new mutations in the virus.. Reservations were further reinforced by reports of violent vaccination reactions.
Government officials and professionals are working to reverse the trend of growing public distrust. “I would love to have myself vaccinated with AstraZeneca as soon as I take it” He said, for example Jens Spahn federal health minister on wednesday.
In a newspaper interview on Thursday, Carsten Watzl, secretary general of the German Society for Immunology (DGfI), suggested that introduce a new procedure whereby a person who receives a two-dose AstraZeneca vaccine will receive another dose of a vaccine made with another technology in a few months’ time, i.e. from a BioNTech / Pfizer or Moderna vaccine based on the use of so-called messenger ribonucleic acid (mRNA). The expert pointed out that there will be enough vaccines from all approved varieties from the fourth quarter at the latest, so there are no obstacles to the implementation of the plan. (MTI)
Source: Patika Magazin Online by www.patikamagazin.hu.
*The article has been translated based on the content of Patika Magazin Online by www.patikamagazin.hu. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!